Diagnostic Test
Response Evaluation Criteria in Solid Tumors
Diagnostics
Overview
An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Response Evaluation Criteria in Solid Tumors
- Topic type
- Diagnostic Test
- Category
- Diagnostics
- MeSH classification
- E01.789.800.379|N04.761.559.590.800.569|N05.715.360.575.575.800.569
Questions to discuss about Response Evaluation Criteria in Solid Tumors
- What does this topic mean in my situation?
- Which type of healthcare professional should I speak with?
- Are tests, assessments or follow-up appointments needed?
- What treatment options or next steps may be relevant?
- Where can I find reliable information before making decisions?
Finding care related to Response Evaluation Criteria in Solid Tumors
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Response Evaluation Criteria in Solid Tumors
No clinics are currently linked directly to Response Evaluation Criteria in Solid Tumors on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.